These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28456653)

  • 1. Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Int J Pharm; 2017 Jun; 526(1-2):95-105. PubMed ID: 28456653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montmorillonite and Laponite Clay Materials for the Solidification of Lipid-Based Formulations for the Basic Drug Blonanserin: In Vitro and in Vivo Investigations.
    Dening TJ; Thomas N; Rao S; van Looveren C; Cuyckens F; Holm R; Prestidge CA
    Mol Pharm; 2018 Sep; 15(9):4148-4160. PubMed ID: 30067372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
    Dening TJ; Joyce P; Prestidge CA
    J Pharm Sci; 2019 Jan; 108(1):295-304. PubMed ID: 30257194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured Montmorillonite Clay for Controlling the Lipase-Mediated Digestion of Medium Chain Triglycerides.
    Dening TJ; Joyce P; Rao S; Thomas N; Prestidge CA
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):32732-32742. PubMed ID: 27934188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic surface chemistry and nanostructure controls lipolytic product speciation and partitioning during the digestion of inorganic-lipid hybrid particles.
    Dening TJ; Joyce P; Webber JL; Beattie DA; Prestidge CA
    J Colloid Interface Sci; 2018 Dec; 532():666-679. PubMed ID: 30121519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
    Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
    Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
    Yasmin R; Tan A; Bremmell KE; Prestidge CA
    J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersaturating lipid-based solid dispersion of atazanavir provides enhanced solubilization and supersaturation in the digestive aqueous phase.
    Mondal S; Sirvi A; Jadhav K; Sangamwar AT
    Int J Pharm; 2023 May; 638():122919. PubMed ID: 37011828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison across Three Hybrid Lipid-Based Drug Delivery Systems for Improving the Oral Absorption of the Poorly Water-Soluble Weak Base Cinnarizine.
    Joyce P; Yasmin R; Bhatt A; Boyd BJ; Pham A; Prestidge CA
    Mol Pharm; 2017 Nov; 14(11):4008-4018. PubMed ID: 28950059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro.
    Meola TR; Dening TJ; Prestidge CA
    Eur J Pharm Biopharm; 2018 Aug; 129():145-153. PubMed ID: 29857135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations.
    Møller A; Schultz HB; Meola TR; Müllertz A; Prestidge CA
    Eur J Pharm Sci; 2021 Feb; 157():105640. PubMed ID: 33189902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs.
    Yasmin R; Rao S; Bremmell KE; Prestidge CA
    AAPS J; 2016 Jul; 18(4):876-85. PubMed ID: 27048207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
    Keemink J; Mårtensson E; Bergström CAS
    Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs.
    Yasmin R; Rao S; Bremmell K; Prestidge C
    Eur J Pharm Sci; 2017 Jan; 96():508-514. PubMed ID: 27793717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation.
    Khan J; Hawley A; Rades T; Boyd BJ
    J Pharm Sci; 2016 Sep; 105(9):2631-2639. PubMed ID: 26359590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
    Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
    Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.